Manhattan Scientifics (Manhattan Scientifics) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Manhattan Scientifics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Manhattan Scientifics's Free Cash Flow for the three months ended in Dec. 2023 was $-0.01 Mil. Manhattan Scientifics's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Manhattan Scientifics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Manhattan Scientifics's current FCF Yield % is -20.59%.

The historical rank and industry rank for Manhattan Scientifics's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Manhattan Scientifics was 4937.50%. The lowest was -3047.33%. And the median was -630.34%.

MHTX's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -7.14
* Ranked among companies with meaningful FCF Margin % only.

Manhattan Scientifics FCF Margin % Historical Data

The historical data trend for Manhattan Scientifics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manhattan Scientifics FCF Margin % Chart

Manhattan Scientifics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-325.77

-784.00

-842.00

-698.00

Manhattan Scientifics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Manhattan Scientifics's FCF Margin %

For the Medical Devices subindustry, Manhattan Scientifics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Manhattan Scientifics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Manhattan Scientifics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Manhattan Scientifics's FCF Margin % falls into.

Manhattan Scientifics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Manhattan Scientifics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.19	/	0
	=	%

Manhattan Scientifics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.014	/	0
	=	%

Manhattan Scientifics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Manhattan Scientifics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Manhattan Scientifics (Manhattan Scientifics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Manhattan Scientifics Inc (OTCPK:MHTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

244 Fifth Avenue, Suite 2341, New York, NY, USA, 10001

Website

http://www.mhtx.com

Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. The company is focused on technology transfer and commercialization of transformative technologies.

Executives

Chris Theoharis	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Photios Frank Georgiou	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Emmanuel Tsoupanarias	director, officer: Chief Executive Officer	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Leonard Friedman	director	405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Marvin Maslow	director, 10 percent owner, officer: Chief Executive Office	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
David Teich	director, officer: Treasurer	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
Ralph Anderson	director	641 FIFTH AVENUE SUITE 36F, NEW YORK NY 10022
Larry H Schatz	director	152 W. 57TH STREET, 31ST FLOOR, NEW YORK NY 10019
Marty Steinberg	10 percent owner	1111 BRICKELL AVENUE SUITE 2500, MIAMI FL 33131
Scott Bach	director, officer: Secretary	MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022

Manhattan Scientifics (Manhattan Scientifics) Headlines

No Headlines